Allergic contact dermatitis from pharmaceutical grade BHA in Timodine®, with no patch test reaction to analytical grade BHA

Contact Dermatitis

Volumn 44, Issue 3, 2001, Pages 191-192

  Orton, D I ^a   Shaw, S ^a  

^a AMERSHAM HOSPITAL   (United Kingdom)

Author keywords

Allergic contact dermatitis; Antioxidants; BHA; Butyl hydroxyanisole; Medicaments; Timodine cream

Indexed keywords

BUTYLATED HYDROXYANISOLE; HYDROCORTISONE; NYSTATIN; TIMODINE;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; CREAM; DISEASE EXACERBATION; DRUG FORMULATION; DRUG HYPERSENSITIVITY; HUMAN; MALE; NEURODERMATITIS; PATCH TEST; SKIN ALLERGY; TECHNIQUE;

ADMINISTRATION, TOPICAL; AGED; ANTI-INFLAMMATORY AGENTS; ANTIFUNGAL AGENTS; BENZALKONIUM COMPOUNDS; BUTYLATED HYDROXYANISOLE; DERMATITIS, ALLERGIC CONTACT; DRUG COMBINATIONS; DRUG COMPOUNDING; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; NYSTATIN; PATCH TESTS; SIMETHICONE;

EID: 0035156257     PISSN: 01051873     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0536.2001.440308-12.x     Document Type: Article

References (6)

1. Contact dermatitis from butylated hydroxyanisole
2. Dermatitis from butylated hydroxy anisole
3. Antioxidants in cosmetics
4. Contact dermatitis from antioxidants
5. Contact sensitivity to nystatin in Timodine
6. Allergic contact dermatitis from dibutyl phthalate, propyl gallate and hydrocortisone in Timodine®